Clinical trial
Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes…
NCT00028951 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00028951 |
|---|---|
| Title | Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva |
| Official title | A Phase III Clinical Trial Use of TISSEEL VH Fibrin Sealant to Reduce Lymphedema Incidence After Inguinal Lymph Node Dissection Performed in the Management of Vulvar Malignancies |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphedema, Perioperative/Postoperative Complications, Vulvar Cancer |
| Intervention type | Drug, Procedure |
| Interventions | fibrin sealant, surgical wound closure |
| Start date | Jan 1, 2003 |
| Primary completion | Dec 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 9, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: